# Clinical Study of KDT-3594 in Healthy Adult Males and Patients With Parkinson's Disease

> **NCT03068481** · PHASE1 · COMPLETED · sponsor: **Kissei Pharmaceutical Co., Ltd.** · enrollment: 36 (actual)

## Conditions studied

- Parkinson Disease

## Interventions

- **DRUG:** KDT-3594
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT03068481
- **Lead sponsor:** Kissei Pharmaceutical Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-02-20
- **Primary completion:** 2018-08-13
- **Final completion:** 2018-08-13
- **Target enrollment:** 36 (ACTUAL)
- **Last updated:** 2019-04-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03068481

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03068481, "Clinical Study of KDT-3594 in Healthy Adult Males and Patients With Parkinson's Disease". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT03068481. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*